Trial intelligence / Profile preview

Safety of Avamys in Vietnamese Adults with PAR

NCT01270958Phase 4Completed

Sponsor
GSK
Start
Aug 2009
Primary completion
Feb 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Aug 2009; status: completed.

02

Drugs

fluticasone
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT01270958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01270958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call